Bracebridge Capital, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 81 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bracebridge Capital, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$524,000
+2.7%
50,0000.0%0.14%
+191.7%
Q4 2022$510,000
+1.4%
50,0000.0%0.05%
-46.1%
Q3 2022$503,0000.0%50,0000.0%0.09%
+11.2%
Q2 2022$503,000
+0.8%
50,0000.0%0.08%
+116.2%
Q1 2022$499,000
-0.2%
50,0000.0%0.04%
+19.4%
Q4 2021$500,00050,0000.03%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q4 2021
NameSharesValueWeighting ↓
FIFTH LANE CAPITAL, LP 30,000$1,030,0000.65%
Wealthspring Capital LLC 243,391$2,423,0000.46%
Spartan Fund Management Inc. 150,000$1,484,0000.31%
HGC Investment Management Inc. 1,000,000$10,020,0000.31%
Atalaya Capital Management LP 250,000$2,518,0000.30%
Schechter Investment Advisors, LLC 110,221$1,090,0000.11%
Bracebridge Capital, LLC 50,000$503,0000.08%
Sage Mountain Advisors LLC 25,610$253,0000.04%
Calamos Advisors LLC 1,000,000$10,070,0000.04%
LMR Partners LLP 250,000$2,515,0000.04%
View complete list of BIOPLUS ACQUISITION CORP shareholders